A Comprehensive Review on Nanomedicine Investigation

Abstract

A relatively new area that is rapidly evolving is nanomedicine. The nanoscale formulation of drugs offers many physical and biological benefits. In turn, these benefits will translate into increased clinical effectiveness and decreased toxicity. Although approximately 50 nano therapeutics have already entered clinical practice, for a variety of indications, a higher number of drugs are undergoing clinical examination. The goal of this analysis is to analyse all of the nano formulations currently undergoing clinical investigation and their ultimate clinical translation outlook. The relatively new field of science is nanomedicine, the application of nanotechnology to health and medicine. While nanotechnology has many applications in medicine, the development of nanoparticle-based therapeutics has been a key application. Physical benefits such as increased solubility, decreased degradation or physiological clearance rates, decreased systemic toxicity, and improved clinical effectiveness are imparted by the introduction of nano materials into the drug formulation (nano formulation). Many of these features are not intrinsic to individual particles due to rapid developments in material sciences, but are under tuneable control, enabling the precise production of drug delivery vehicles with the most desirable physical properties.